triumph 1 trial retatrutide TRIUMPH-1: Biggest Obesity Result 2026 triumph 1 retatrutide First phase

This will be a Phase 2type study enrolling approximately 100 patients with moderate to severe CUD, who will receive weekly Tirzepatide or placebo over about 24 weeks

We classified prescriptions of Wegovy (approved for overweight and obesity) as on-label if the patient had a history of BMI 27 or documentation of obesity, and off-label otherwise

To learn more about how GLP-1 medications fit into your weight loss program, contact a healthcare provider or consult with Boston Medical Group to create a personalized GLP-1 nutrition puzzle that aligns with your goals for effective weight loss treatment.

MTA does not practice medicine, make diagnoses, or control the clinical judgment of any provider

Learn why insomnia happens and get practical tips to sleep better while taking GLP-1s